CL2012001262A1 -
Spiropiperidine derived compounds; pharmaceutical composition; and use as orl-1 receptor antagonists in the treatment of depression, migraine, obesity.
- Google Patents
Spiropiperidine derived compounds; pharmaceutical composition; and use as orl-1 receptor antagonists in the treatment of depression, migraine, obesity.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of CL2012001262A1publicationCriticalpatent/CL2012001262A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
COMPUESTOS DERIVADOS DE ESPIROPIPERIDINA DE LA FÓRMULA: COMPOSICIÓN FARMACÉUTICA; Y USO COMO ANTAGONISTAS DEL RECEPTOR ORL -1 EN EL TRATAMIENTO DE LA DEPRESIÓN, MIGRAÑA. OBESIDAD.COMPOUNDS DERIVED FROM SPIROPIPERIDINE IN THE FORMULA: PHARMACEUTICAL COMPOSITION; AND USE AS ANTAGONISTS OF THE ENT-1 RECEPTOR IN THE TREATMENT OF DEPRESSION, MIGRAINE. OBESITY.
CL2012001262A2009-11-162012-05-15
Spiropiperidine derived compounds; pharmaceutical composition; and use as orl-1 receptor antagonists in the treatment of depression, migraine, obesity.
CL2012001262A1
(en)
Spiropiperidine derived compounds; pharmaceutical composition; and use as orl-1 receptor antagonists in the treatment of depression, migraine, obesity.
Compounds derived from substituted 4-phenyl-pyridines, modulators of the nk1 receptor; preparation procedure; pharmaceutical composition; and its use in the treatment of emesis, bladder dysfunction, depression or anxiety
Compounds derived from spiropiperidine-methylbenzyloxyphenyl, activators of the rpg-40 receptor; pharmaceutical composition comprising them; and use of the compound to treat diabetes.
Compounds derived from amides, modulators of the taar1 receptor; obtaining process; pharmaceutical composition; and use in the treatment of diseases such as depression, anxiety, stress, among others.
Piperidine derived compounds; pharmaceutical composition; and its use as acetyl-coa carboxylase inhibitors for the treatment of metabolic disorders, such as obesity and diabetes.
Compounds derived from (piperidin-4-yl) -ureas; pharmaceutical composition; and use as antagonists of the ghrelin receptor in the treatment of obesity, eating disorders, diabetes, cachexia caused by cancer, congestive heart failure, among others.
Compounds derived from 4-azetidinyl-1-heteroaryl-cyclohexanol; pharmaceutical composition; and use in the treatment of diseases such as epoc, atherosclerosis, rheumatoid arthritis, among others.
Compounds derived from cycloguanidine substituted pyrimidinedione and triazinedione, useful as a prokineticin receptor antagonist; pharmaceutical composition comprising said compounds; and use in the treatment of gastrointestinal diseases.